Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEFAZODONE vs NEFOPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NEFAZODONE vs NEFOPAM: Safety Overview

Metric NEFAZODONE NEFOPAM
Total FAERS Reports 284 2,857
Deaths Reported 11 360
Death Rate 3.9% 12.6%
Hospitalizations 37 1,685
Average Patient Age 56.4 yrs 55.0 yrs
% Female Patients 66.6% 54.4%
FDA Approval Date Dec 22, 1994 N/A
Manufacturer Teva Pharmaceuticals USA, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A